ConductScience.org, home

Paper8400331

Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.

Kennedy MJ and 1 other. Breast Cancer Res Treat, 1993. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation. Papers, record 8400331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8400331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.
PubMed
Journal
Breast Cancer Res Treat
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2019-09-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kennedy MJM J
2Jones RJR J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Bone Marrow TransplantationMajor topic
Breast NeoplasmsMajor topic
Graft vs Host DiseaseMajor topic
ImmunotherapyMajor topic
Animals
Combined Modality Therapy
Cyclosporine
Dose-Response Relationship, Drug
Female
Humans
Interferon-gamma

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 58270-01NCI NIH HHSUnited StatesPubMedPubMed
U01CA058270NIHNIH RePORTER

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134792Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.N Engl J Med1979https://conductscience.org/library/papers/34792PubMed
21357109High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.J Clin Oncol1992https://conductscience.org/library/papers/1357109PubMed
33918946Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.Int J Cancer1985https://conductscience.org/library/papers/3918946PubMed
46336658Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.Cancer Res1983https://conductscience.org/library/papers/6336658PubMed
56403654Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.J Exp Med1983https://conductscience.org/library/papers/6403654PubMed
62049460Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies.Ann Hematol1991https://conductscience.org/library/papers/2049460PubMed
72815290Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants.Transplant Proc1989https://conductscience.org/library/papers/2815290PubMed
82459333HLA class II sublocus expression in benign and malignant breast epithelium.J Pathol1988https://conductscience.org/library/papers/2459333PubMed
98445424Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.J Clin Oncol1993https://conductscience.org/library/papers/8445424PubMed
101740685
Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
J Clin Oncol1992https://conductscience.org/library/papers/1740685PubMed
113924395Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.Cancer Res1985https://conductscience.org/library/papers/3924395PubMed
121727912A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.J Clin Oncol1992https://conductscience.org/library/papers/1727912PubMed
138435355Reversal of multidrug resistance in breast cancer: many more open questions than answers.Ann Oncol1993https://conductscience.org/library/papers/8435355PubMed
142502208Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.Blood1989https://conductscience.org/library/papers/2502208PubMed
152580038
Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.
J Exp Med1985https://conductscience.org/library/papers/2580038PubMed
163043792Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period.Transplantation1988https://conductscience.org/library/papers/3043792PubMed
172941082Immunologic classification of leukemia and lymphoma.Blood1986https://conductscience.org/library/papers/2941082PubMed
187015133Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.N Engl J Med1981https://conductscience.org/library/papers/7015133PubMed
191991174Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.Blood1991https://conductscience.org/library/papers/1991174PubMed
203047332High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.J Clin Oncol1988https://conductscience.org/library/papers/3047332PubMed

See all 34 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
12621492Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).Bone Marrow Transplant2003https://conductscience.org/library/papers/12621492PubMed
8825121Immunomodulation following chemotherapy.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8825121PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8400331

GET https://conductscience.org/api/papers/v1/8400331/references?page=2